MS4A12 and colonic neoplasm: MS4A12 is a novel component of store-operated [Ca2+] entry in intestinal cells, and loss of MS4A12 in LoVo colon cancer cells attenuates epidermal growth factor receptor-mediated signaling, thereby promoting colonic carcinoma migration (9).